IMDELLTRA J Code: J9026

Drug & Product Overview

HCPCS Descriptor Injection, tarlatamab-dlle, 1 mg

HCPCS Added Date January 1, 2025

Manufacturer Amgen

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About IMDELLTRA

Imdelltra is a medication aligned to the HCPCS J Code: J9026 for billing, pricing, and reimbursement purposes in the United States. Classified under Anti-Emetic, it is administered via the intravenous route and manufactured by Amgen.

According to CMS Drug Use Information: This medication is used to treat a certain type of cancer (extensive stage small cell lung cancer - ES-SCLC). Tarlatamab works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 2 of 4 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
55513-0059-01	Imdelltra (Amg757)	Amgen, Inc	1	1 MG
55513-0077-01	Imdelltra (Amg757)	Amgen, Inc	10	10 MG
•••••-••••-•• Log in to view	IMDELLTRA
	IMDELLTRA

Login to view 2 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

IMDELLTRA Pricing & Reimbursement

J9026 Private Payer Reimbursement

$1,610.78 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

IMDELLTRA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 15.05%

Avg. Days to File 9.1days

Avg. Days to Pay 24.5days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9026 claims analytics on FocalPoint →

IMDELLTRA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

IMDELLTRA Medically Unlikely Edits (MUE)

The most billing units of J9026 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

10 units / day

= 10 mg per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

IMDELLTRA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Frequently Asked Questions

Is there an available IMDELLTRA billing and coding guide?

Billing and coding information for IMDELLTRA can be found through Amgen Inc. Visit Here →

What are the available IMDELLTRA patient assistance programs?

IMDELLTRA patient assistance information can be found through Amgen Inc. Visit Here →

Where can I find IMDELLTRA prescribing information?

IMDELLTRA prescribing information can be found at the link below. Visit Here →

Where can I find IMDELLTRA side effect information?

IMDELLTRA side effect information can be found through MedlinePlus at the link below.

Does billing IMDELLTRA require JZ/JW wastage modifiers?

CMS does not include IMDELLTRA (J9026) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9026. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.